Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS
View through CrossRef
Purpose:
To report management of de novo vitreous amyloid opacities after previous pars plana vitrectomy in familial amyloidotic polyneuropathy transthyretin Val30Met.
Methods:
This work is a retrospective observational consecutive case series of five eyes of four patients. Demographic data, transthyretin mutation involved, age at the beginning of disease, duration of disease, treatment (liver transplant or tafamidis), time between vitrectomy and re-intervention, and ophthalmologic changes were evaluated. Surgical re-intervention included phacoemulsification with intraocular lens implantation in phakic eyes, re-vitrectomy as complete as possible with posterior capsulectomy, and internal limiting membrane peeling if wrinkling of internal retinal surface was present.
Results:
All patients had transthyretin Val30Met mutation, and three were women. Mean age of onset of the disease was 52 ± 11.0 years, and average evolution time of the disease was 8 years. Three patients had been submitted to liver transplant 4, 9, and 15 years before. Time between first vitrectomy and surgical re-intervention was longer than 2 years in all cases. Two eyes had amyloid deposits on anterior lens surface and pupillary border with scalloped pupil. Two eyes were phakic. Glaucoma was present in two eyes; one of them had previous trabeculectomy. All cases had vitreous opacities behind posterior lens capsule and at vitreous base area. After re-intervention, no further recurrence was observed (average follow-up of 10 months).
Conclusion:
De novo vitreous amyloid opacities may occur several years after pars plana vitrectomy. Amyloid deposition in vitreous cavity was observed only in strong vitreous adherence locations (behind posterior lens capsule and at vitreous base area). The authors expect that this procedure, an extensive re-vitrectomy associated with posterior capsulectomy, will prevent de novo vitreous amyloid opacities.
Ovid Technologies (Wolters Kluwer Health)
Title: RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS
Description:
Purpose:
To report management of de novo vitreous amyloid opacities after previous pars plana vitrectomy in familial amyloidotic polyneuropathy transthyretin Val30Met.
Methods:
This work is a retrospective observational consecutive case series of five eyes of four patients.
Demographic data, transthyretin mutation involved, age at the beginning of disease, duration of disease, treatment (liver transplant or tafamidis), time between vitrectomy and re-intervention, and ophthalmologic changes were evaluated.
Surgical re-intervention included phacoemulsification with intraocular lens implantation in phakic eyes, re-vitrectomy as complete as possible with posterior capsulectomy, and internal limiting membrane peeling if wrinkling of internal retinal surface was present.
Results:
All patients had transthyretin Val30Met mutation, and three were women.
Mean age of onset of the disease was 52 ± 11.
0 years, and average evolution time of the disease was 8 years.
Three patients had been submitted to liver transplant 4, 9, and 15 years before.
Time between first vitrectomy and surgical re-intervention was longer than 2 years in all cases.
Two eyes had amyloid deposits on anterior lens surface and pupillary border with scalloped pupil.
Two eyes were phakic.
Glaucoma was present in two eyes; one of them had previous trabeculectomy.
All cases had vitreous opacities behind posterior lens capsule and at vitreous base area.
After re-intervention, no further recurrence was observed (average follow-up of 10 months).
Conclusion:
De novo vitreous amyloid opacities may occur several years after pars plana vitrectomy.
Amyloid deposition in vitreous cavity was observed only in strong vitreous adherence locations (behind posterior lens capsule and at vitreous base area).
The authors expect that this procedure, an extensive re-vitrectomy associated with posterior capsulectomy, will prevent de novo vitreous amyloid opacities.
Related Results
Pars Plana Vıtrectomy Results In Prolıferatıve Vıtreoretınopathıes
Pars Plana Vıtrectomy Results In Prolıferatıve Vıtreoretınopathıes
Objective: To evaluate the clinical features, surgical treatment
results and complications of patients who underwent pars plana vitrectomy for
proliferative vitreoretinopathy(PVR) ...
Visualoutcome Pada Pasien Retinopati Diabetik Pasca Operasi Pars Plana Vitrektomi Di Rumah Sakit Pertamina Bintang Amin Provinsi Lampung Tahun 2020/2021
Visualoutcome Pada Pasien Retinopati Diabetik Pasca Operasi Pars Plana Vitrektomi Di Rumah Sakit Pertamina Bintang Amin Provinsi Lampung Tahun 2020/2021
ABSTRACT: VISUAL RESULTS OF DIABETES RETINOPATHY PATIENTS POST PARS PLANA VITRECTOMY OPERATION AT PERTAMINA BINTANG AMIN HOSPITAL Background: Diabetic retinopathy is a neovascular ...
Effect of the N‐terminal sequence on the binding affinity of transthyretin for human retinol‐binding protein
Effect of the N‐terminal sequence on the binding affinity of transthyretin for human retinol‐binding protein
During vertebrate evolution, the N‐terminal region of transthyretin (TTR) subunit has undergone a change in both length and hydropathy. This was previously shown to change the bind...
Abstract Thu027: Preliminary Evidence for In Vitro Intrinsic Production of Misfolded Transthyretin by Patient iPSC-Derived Cardiomyocytes
Abstract Thu027: Preliminary Evidence for In Vitro Intrinsic Production of Misfolded Transthyretin by Patient iPSC-Derived Cardiomyocytes
Background:
Cardiac amyloidosis is a severe condition characterized by the deposition of misfolded amyloid fibrils in the heart, leading to restrictive cardiomyopathy a...
Transthyretin -Related Familial Amyloid Polyneuropathy (TTR-FAP) Polineuropathy – Challenge Diagnosis and Case Presentation
Transthyretin -Related Familial Amyloid Polyneuropathy (TTR-FAP) Polineuropathy – Challenge Diagnosis and Case Presentation
Abstract
Introduction Transthyretin -Related Familial Amyloid Polyneuropathy (TTR-FAP) is a rare cause of polyneuropathy, mainly in Romania, but also in other geo...
TTR-INR guided warfarin adjustment protocol: A strategy to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin
TTR-INR guided warfarin adjustment protocol: A strategy to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin
AbstractBackground:Atrial fibrillation (AF) is a causing ischemic stroke. Warfarin remains a viable oral anticoagulant for many patients. Time in therapeutic range (TTR) is still n...
EARLY DESCRIPTIONS OF VITREOUS SURGERY
EARLY DESCRIPTIONS OF VITREOUS SURGERY
Background:
Vitreoretinal surgical techniques have evolved during the last decades because of the development and evolution of pars plana vitrectomy. The introduction o...
Quality of Oral Anticoagulation with Vitamin K Antagonists in 'Real-World' Patients: Lessons from a Six Years Audit Study
Quality of Oral Anticoagulation with Vitamin K Antagonists in 'Real-World' Patients: Lessons from a Six Years Audit Study
Introduction: Among patients receiving vitamin K antagonists (VKA) therapy, maintenance of an international normalized ratio (INR) in the therapeutic range is essential for treatme...